Back
BridgeBio Pharma 10K Form
Sell
39
BBIO
BridgeBio Pharma
Last Price:
$26.49
Seasonality Move:
-20.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBIO News And Ratings
See the #1 stock for the next 7 days that we like better than BBIO
BBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $9.3M |
|---|---|
| Cash Flow: | $-182.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-6.51 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.41000 |
|---|---|
| Net Income (TTM): | $-438.9M |
| Gross Margin: | $6.9M |
| Return on Equity: | 0% |
| Return on Assets: | -62.51% |
BridgeBio Pharma Earnings Forecast
Key BridgeBio Pharma Financial Ratios
-
The Gross Profit Margin over the past 7 years for BBIO is 73.71%.
-
The Selling, General & Administrative Expenses for BBIO have been equal to 1,618.73% of Gross Profit Margin.
-
The Research & Development expenses have been 4,898.54% of Revenue.
-
The Interest Expense is -12.64% of Operating Income.
-
The Net Earning history of BBIO is -6,913.92% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
BridgeBio Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBIO |
| CUSIP: | 10806X |
| Website: | bridgebio.com |
Debt
| Debt-to-Equity Ratio: | -1.4 |
|---|---|
| Current Ratio: | 3.19 |
| Quick Ratio: | 1.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBIO Technical Analysis vs Fundamental Analysis
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $26.50. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.